ARCHIVES

20% of Women Do Not Believe Tailored Risk Assessments

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

In Brief: John Mendelson To Succeed LaMaistre As President, M.D Anderson Cancer Center

May 17, 1996

In Brief: George Weiner to become president of AACI

September 5, 2014